| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/07/1995 | US5387744 Avirulent microbes and uses therefor: Salmonella typhi |
| 02/07/1995 | US5387742 Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387673 Active fragments of fibroblast growth factor |
| 02/07/1995 | US5387521 Bacillus for hyperproduction of enzyme comprising enzyme structural gene linked to functional promoter sequence, two or more mutated transcriptional regulatory genes |
| 02/07/1995 | US5387519 Recombinant avipoxvirus |
| 02/07/1995 | US5387510 Detection of amplified nucleic acid using secondary capture oligonucleotides and test kit |
| 02/07/1995 | US5387505 Preparation and isolation of single-stranded biotinylated nucleic acids by heat avidin-biotin cleavage |
| 02/07/1995 | US5387414 Comprising peptide immunogen with novel epitopes |
| 02/02/1995 | WO1995003547A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | WO1995003432A1 Linked linear amplification of nucleic acids |
| 02/02/1995 | WO1995003430A1 Methods for enhancing nucleic acid amplification |
| 02/02/1995 | WO1995003428A1 In vivo nucleic acid hybridization method |
| 02/02/1995 | WO1995003427A2 Oligonucleotide screening assay |
| 02/02/1995 | WO1995003426A2 Method for nucleic acid amplification by transcription using displacement, and reagents and kit therefor |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003418A2 Recombinant bcg vaccines |
| 02/02/1995 | WO1995003417A2 Homologously recombinant slow growing mycobacteria and uses therefor |
| 02/02/1995 | WO1995003416A1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003413A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 02/02/1995 | WO1995003412A2 Nucleotide fragment of mycobacterial ribosomal rna 23s, probes and primers derived therefrom, reagent and method for detecting said fragment |
| 02/02/1995 | WO1995003411A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | WO1995003410A2 Guanylatcyclase activating peptide i (gcap-i) coding gene |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003407A2 Oligonucleotides with activity against human immunodeficiency virus |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003404A1 Dna virus ribozymes |
| 02/02/1995 | WO1995003402A1 EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL |
| 02/02/1995 | WO1995003401A1 Method for screening unknown organisms |
| 02/02/1995 | WO1995003400A1 Recombinationally targeted cloning in yeast artificial chromosomes |
| 02/02/1995 | WO1995003399A2 Production method for preparation of disabled viruses |
| 02/02/1995 | WO1995003397A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | WO1995003334A1 Antibodies specific for human prostate glandular kallikrein |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003331A1 Human mhc class ii double transgene and uses |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003325A1 Protegrins |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003322A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003070A1 Recombinant swinepox virus |
| 02/02/1995 | WO1995003069A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | WO1995003065A1 Scorpion peptide with immunosuppressant activity |
| 02/02/1995 | WO1994029452A3 Enzymatic rna molecules and their application in the treatment of fibrosis and fibrous tissue disease |
| 02/02/1995 | WO1994029447A3 Dna coding for the human thyrotropin-releasing hormone receptor |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994029442A3 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | WO1994028180A3 Fruit with modified nadp-linked malic enzyme activity |
| 02/02/1995 | WO1994028136A3 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes |
| 02/02/1995 | WO1994028129A3 Tumour metastasis gene |
| 02/02/1995 | WO1994026925A3 Processes for producing an enzyme |
| 02/02/1995 | WO1994018329A3 Serine protease variants having peptide ligase activity |
| 02/02/1995 | DE4325699A1 Recombinant DNA construct |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2168110A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | CA2167840A1 Linked linear amplification of nucleic acids |
| 02/02/1995 | CA2167808A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | CA2167804A1 In vivo nucleic acid hybridization method |
| 02/02/1995 | CA2167701A1 Dna virus ribozymes |
| 02/02/1995 | CA2167677A1 Method for the high level expression, purification and refolding of the outer membrane group b porin proteins from neisseria meningitidis |
| 02/02/1995 | CA2167581A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | CA2167580A1 Expression of human interleukin-1.beta. in a transgenic animal |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167267A1 Methods for determining the invasiveness of a bladder tumor |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | CA2166788A1 Protegrins |
| 02/02/1995 | CA2166616A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/02/1995 | CA2145172A1 Nucleotide fragment of mycobacterial ribosomal rna 23s, probes and primers derived therefrom, reagent and method for detecting said fragment |
| 02/01/1995 | EP0636696A1 Process for producing major histocompatibility antigen class ii protein and material having the same immobilized thereon |
| 02/01/1995 | EP0636694A2 Human and human-like thymopoietin, method for its production and recombinant DNA sequences encoding it |
| 02/01/1995 | EP0636413A2 Nucleic acid amplification reaction apparatus and method |
| 02/01/1995 | EP0636310A1 Doubled haploids |
| 02/01/1995 | EP0636187A1 NUCLEOTIDIC SEQUENCES HYBRIDIZING SPECIFICALLY WITH A $i(CAMPYLOBACTER JEJUNI) GENOMIC NUCLEIC SEQUENCE |
| 02/01/1995 | EP0636186A1 Probe composition and method |
| 02/01/1995 | EP0636185A1 Electrochemical treatment of nucleic acid containing solutions |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636181A1 Newly characterised oxalate oxidase and uses therefor |
| 02/01/1995 | EP0636180A1 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/01/1995 | EP0636179A1 Oil-body proteins as carriers of high-value peptides in plants |
| 02/01/1995 | EP0636178A1 Protocadherin, their autibodies and uses |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636175A1 Decorin fragments and methods of inhibiting cell regulatory factors |
| 02/01/1995 | EP0636174A1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636172A1 Genetically engineered attenuated viruses |
| 02/01/1995 | EP0636145A1 Synthetic polypeptides derived from the hiv envelope glycoprotein |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |